Pharmaceuticals for Women's Health is the generic name for specific diseases such as postmenopausal osteoporosis, endometriosis, polycystic ovary syndrome, pregnancy disorders, etc.
This report contains market size and forecasts of Pharmaceuticals for Women's Health in Global, including the following market information:
Global Pharmaceuticals for Women's Health Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceuticals for Women's Health market was valued at 26920 million in 2021 and is projected to reach US$ 31560 million by 2028, at a CAGR of 2.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Granules Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceuticals for Women's Health include Allergan, Lilly, Pfizer, Bayer, AbbVie, Amgen and Johnson＆Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceuticals for Women's Health companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceuticals for Women's Health Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceuticals for Women's Health Market Segment Percentages, by Type, 2021 (%)
Granules
Pills
Powder
Tincture
Tablets
Capsule
Other
Global Pharmaceuticals for Women's Health Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceuticals for Women's Health Market Segment Percentages, by Application, 2021 (%)
Postmenopausal Osteoporosis
Endometriosis
Polycystic Ovarian Syndrome
Pregnancy Disorders
Others
Global Pharmaceuticals for Women's Health Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmaceuticals for Women's Health Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceuticals for Women's Health revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceuticals for Women's Health revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Lilly
Pfizer
Bayer
AbbVie
Amgen
Johnson＆Johnson